Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Shares Outstanding (Weighted Average)
Others
Ratios

RAPT Therapeutics (RAPT) EPS (Basic): 2018-2023

Historic EPS (Basic) for Therapeutics (RAPT) over the last 6 years, with Dec 2023 value amounting to -$3.05.

  • Therapeutics' EPS (Basic) fell 24.62% to -$0.81 in Q4 2023 from the same period last year, while for Dec 2023 it was -$3.05, marking a year-over-year decrease of 17.76%. This contributed to the annual value of -$3.05 for FY2023, which is 18.22% down from last year.
  • Therapeutics' EPS (Basic) amounted to -$3.05 in FY2023, which was down 18.22% from -$2.58 recorded in FY2022.
  • In the past 5 years, Therapeutics' EPS (Basic) ranged from a high of -$2.19 in FY2020 and a low of -$9.89 during FY2019.
  • For the 3-year period, Therapeutics' EPS (Basic) averaged around -$2.72, with its median value being -$2.58 (2022).
  • Its EPS (Basic) has fluctuated over the past 5 years, first plummeted by 117.03% in 2019, then surged by 77.86% in 2020.
  • Over the past 5 years, Therapeutics' EPS (Basic) (Yearly) stood at -$9.89 in 2019, then surged by 77.86% to -$2.19 in 2020, then fell by 15.53% to -$2.53 in 2021, then fell by 1.98% to -$2.58 in 2022, then fell by 18.22% to -$3.05 in 2023.